Measurement-Based Care for Inflammatory Bowel Disease

(MBC-IBD Trial)

This trial aims to help people with Inflammatory Bowel Disease (IBD), a chronic condition that affects daily life. The researchers seek to determine if a new approach, called Measurement-Based Care (MBC), can improve quality of life and reduce flare-ups through close monitoring between clinic visits. Participants will either receive the new MBC approach, known as the MBC-IBD Intervention, or continue with standard care, which includes regular check-ups and educational materials. Veterans who feel their IBD significantly impacts their daily life might find this trial suitable. As an unphased trial, this study provides a unique opportunity to explore innovative care strategies that could enhance daily living for those with IBD.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that measurement-based care (MBC) for inflammatory bowel disease (IBD) is safe for patients. MBC uses information from patient surveys to monitor symptoms and track treatment effectiveness over time. This method helps patients manage their condition better between doctor visits by keeping their healthcare team regularly updated.

MBC does not involve new drugs or invasive procedures, reducing the risk of side effects. It enhances communication and monitoring through self-reported questionnaires. Patients find it easy to use, with no reports of negative effects linked to MBC itself.

Researchers are excited about the MBC-IBD intervention because it offers a new way to manage inflammatory bowel disease by integrating measurement-based care into routine treatment. Unlike the standard care that relies heavily on clinic visits and routine biomarker assessments, MBC-IBD uses technology to provide continuous care. Patients receive automated reminders to complete weekly surveys, allowing for real-time tracking of symptoms and treatment effectiveness. This approach aims to keep patients more engaged in their care and could lead to better health outcomes by identifying issues early and adjusting treatment plans in a timely manner.

Research has shown that Measurement-Based Care (MBC) can effectively manage inflammatory bowel disease (IBD). In this trial, participants in the MBC-IBD arm will use patient-reported outcomes (PROs), such as surveys about pain and other symptoms, to help doctors identify issues early and adjust treatments more quickly. This method aims to improve quality of life and reduce hospital visits by allowing for closer monitoring between doctor appointments. Early results indicate that patients feel more in control of their symptoms, leading to better overall health management. Overall, MBC for IBD appears promising in making life easier for those living with the condition.¹³⁶⁷⁸